about
Emergency action plans for people at risk of anaphylaxis (major allergy)Emergency action plans for people at risk of anaphylaxis (major allergy)Adrenaline (epinephrine) for the treatment of anaphylaxis with and without shockAdrenaline for the treatment of anaphylaxis with and without shockH1-antihistamines for the treatment of anaphylaxis with and without shockH1-antihistamines for the treatment of anaphylaxis with and without shockSerious shortcomings in the management of children with anaphylaxis in Scottish schoolsImplementation of anaphylaxis management guidelines: a register-based studyEthical principles as a guide in implementing policies for the management of food allergies in schools.Exploiting the potential of routine data to better understand the disease burden posed by allergic disorders.World allergy organization guidelines for the assessment and management of anaphylaxis.Demographic and clinical characteristics of patients with anaphylactic shock after surgery for cystic echinococcosisBiphasic anaphylaxis to gemifloxacin.Living with severe allergy: an Anaphylaxis Campaign national survey of young people.Factors Associated with Echinococcosis-Induced Perioperative Anaphylactic Shock.Management of anaphylaxis in the emergency setting.Drug-induced anaphylaxis: a decade review of reporting to the Portuguese Pharmacovigilance Authority.BSACI guideline for the diagnosis and management of peanut and tree nut allergy.Anaphylaxis: epidemiology, aetiology and relevance for the clinic.Anaphylaxis in an urban Belgian emergency department: epidemiology and aetiology.Anaphylaxis admissions to UK critical care units between 2005 and 2009.Twenty four-hour helpline access to expert management advice for food-allergy-triggered anaphylaxis in infants, children and young people: a pragmatic, randomized controlled trial.Anaphylaxis in Israel: experience with 92 hospitalized children.Strategies for living with the risk of anaphylaxis in adolescence: qualitative study of young people and their parents.
P2860
Q24185841-54CA9B4F-E99A-497B-84C1-AFF2DAA91A83Q24200750-1D65E3C0-2E01-457A-BD93-6660C7A4271CQ24241174-CF487A1F-2B65-44DF-A032-2821A89A3DDCQ24243567-8C60170A-CA26-4178-8B75-00DB714ECD8CQ24245913-8B987249-4BEA-42CA-8031-2B6E9BB95ED2Q24246206-7E3D50BE-15E2-4A18-BFD3-B0B677C76EF3Q28469039-92E932B2-BD19-44A0-BB00-7E7620418BF0Q28730033-F55C9ADD-2DE3-4F89-83EF-87F4F951DF88Q30227234-544A07EF-54B2-4A4C-8F91-EC9FBF9A4925Q31048676-DE83342E-6203-429A-BF42-BEC4A500D2A1Q34319703-3C77F591-8646-4FA6-98A4-25F0DE303E37Q35186807-6D4EECE3-4BCE-4679-9F6E-0804D85FBE0EQ36365197-CC265699-421B-400A-B38E-04091CF3F92CQ36575537-73CC51E4-4F5B-47D8-81BA-A5DCE7AE4BF1Q37606593-0511B11C-130E-4547-826A-1EF75093826FQ37729047-D5498E16-7FFC-4253-97C6-21283CFEB163Q38036926-F27AE3A6-0B94-449E-94F0-BFFCBA9B9854Q38610629-1B2F9869-90EE-4533-A759-AC160C33F404Q39340740-472631B8-2FE5-4AB1-ADF6-5B5DCC7B5E12Q40302562-AB166A53-BD6F-4A00-9A18-441E3C1BC5CCQ45190779-F0BB6A79-3185-44F2-AD96-83F63782719CQ48099248-E9004D34-CEB3-41BF-A482-7E0D563A6A7DQ48351960-1982B3C0-E73A-42FB-B1A6-F2BACBA5B19AQ50791325-35421C29-41BE-4796-9819-FD5DBED81F38
P2860
description
2001 nî lūn-bûn
@nan
2001年の論文
@ja
2001年学术文章
@wuu
2001年学术文章
@zh
2001年学术文章
@zh-cn
2001年学术文章
@zh-hans
2001年学术文章
@zh-my
2001年学术文章
@zh-sg
2001年學術文章
@yue
2001年學術文章
@zh-hant
name
Age specific aetiology of anaphylaxis.
@en
Age specific aetiology of anaphylaxis.
@nl
type
label
Age specific aetiology of anaphylaxis.
@en
Age specific aetiology of anaphylaxis.
@nl
prefLabel
Age specific aetiology of anaphylaxis.
@en
Age specific aetiology of anaphylaxis.
@nl
P356
P1476
Age specific aetiology of anaphylaxis.
@en
P2093
P356
10.1136/ADC.85.4.348B
P407
P577
2001-10-01T00:00:00Z